Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,881–2,888 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Neurocrine Biosciences Inc. INGREZZA - (T-Force GOLD) Tourette syndrome - juvenile Phase 2b Withdrawn oral Neurology
Neurocrine Biosciences Inc. NBI-1065890 CNS Indications Phase 2 Ongoing Oral Neurology
Neurocrine Biosciences Inc. NBI-1070770 Major Depressive Disorder Phase 2 Data Released Oral Psychiatric
Neurocrine Biosciences Inc. Crinecerfont - (adolescent open-label) Classic congenital adrenal hyperplasia (CAH) Phase 2 Data Released Oral Genetic Disorder
Neurocrine Biosciences Inc. NBI-921352 Focal Onset Seizure in Adults Phase 2 Withdrawn Oral Neurology
Neurocrine Biosciences Inc. NBI-827104 Essential Tremor Phase 2 Trial Completed Oral Neurology
Neurocrine Biosciences Inc. Luvadaxistat (NBI-1065844) Cognitive Impairment Associated with Schizophrenia (CIAS) Phase 2 Data Released Oral Psychiatric
Neurocrine Biosciences Inc. VY-AADC02 - (RESTORE-1) Parkinson's Disease Phase 2 Trial Discontinued Intracerebral Neurology